-+ 0.00%
-+ 0.00%
-+ 0.00%

KAILERA THERAPEUTICS - PHASE 2B HIGH-DOSE RIBUPATIDE INJECTION TRIAL FULLY ENROLLED; DATA EXPECTED MID-2027

Reuters·08/12/2026 20:05:01

Please log in to view news